Literature DB >> 18813827

The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer.

Hiroyuki Kato1, Hitoshi Kimura, Masanobu Nakajima, Makoto Sakai, Akihiko Sano, Naritaka Tanaka, Takanori Inose, Ahmad Faried, Kana Saito, Keisuke Ieta, Makoto Sohda, Yasuyuki Fukai, Tatsuya Miyazaki, Norihiro Masuda, Minoru Fukuchi, Hitoshi Ojima, Katsuhiko Tsukada, Noboru Oriuchi, Keigo Endo, Hiroyuki Kuwano.   

Abstract

The purpose of the present study was to assess the contribution of simultaneous functional/anatomical imaging using integrated 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT), compared with PET alone for the evaluation of initial lymph node staging in esophageal cancer. We studied 167 consecutive patients with thoracic esophageal squamous cell carcinoma (SCC) who had radical esophagectomy performed between January 1999 and April 2007. For individual nodal group evaluation, PET/CT showed 46.0% sensitivity (p<0.05 vs. PET), 99.4% specificity, 95.1% accuracy (p<0.05 vs. PET), 87.0% positive and 95.5% negative predictive values. PET showed 32.9% sensitivity, 98.9% specificity, 93.1% accuracy, 74.7% positive predictive value and 93.9% negative predictive value. Thus, the sensitivity and accuracy of PET/CT were significantly higher than those of PET. Comparisons between CT, PET and PET/CT in detecting lymph node metastasis by each region showed that PET/CT had a higher sensitivity in lower thoracic regions than PET and CT (p<0.05 vs. CT and PET). Lymph node staging (N0 vs. N1) was not significantly different, but staging per lymph nodal group was significantly better with PET/CT. Integrated PET/CT imaging with co-registration of anatomic and functional imaging data is useful in the initial lymph node staging of patients with operable esophageal cancer compared with PET alone.

Entities:  

Mesh:

Year:  2008        PMID: 18813827

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

Review 1.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

2.  Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.

Authors:  Hiroyuki Yamada; Masao Hosokawa; Kazuo Itoh; Toshinao Takenouchi; Yoshihiro Kinoshita; Tomohiro Kikkawa; Keita Sakashita; Shion Uemura; Yasunori Nishida; Takaya Kusumi; Shigeyuki Sasaki
Journal:  Surg Today       Date:  2014-07       Impact factor: 2.549

3.  Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.

Authors:  Ryuichi Karashima; Masayuki Watanabe; Yu Imamura; Satoshi Ida; Yoshifumi Baba; Shiro Iwagami; Yuji Miyamoto; Yasuo Sakamoto; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2014-06-28       Impact factor: 2.549

4.  Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.

Authors:  Seong Yong Park; Dae Joon Kim; Hee Suk Jung; Mi Jin Yun; Jeong Won Lee; Cheol Keun Park
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

5.  The role of PET-CT in patients with incidental gallbladder cancer.

Authors:  Jean M Butte; Francisca Redondo; Enrique Waugh; Manuel Meneses; Rossana Pruzzo; Hugo Parada; Horacio Amaral; Hernán A De La Fuente
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

6.  Maximum standardized uptake value in 18F-fluoro-2-deoxyglucose positron emission tomography is associated with advanced tumor factors in esophageal cancer.

Authors:  Takeshi Kajiwara; Yoichi Hiasa; Tomohiro Nishina; Toshihiko Matsumoto; Shinichiro Hori; Seijin Nadano; Haruo Iguchi; Satoru Takeji; Eiji Tsubouchi; Yoshio Ikeda; Morikazu Onji
Journal:  Mol Clin Oncol       Date:  2014-01-07

7.  Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Chenxue Jiang; Yun Chen; Yaoyao Zhu; Yapping Xu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

8.  Esophageal cancer associated with a sarcoid-like reaction and systemic sarcoidosis in lymph nodes: supportive findings of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography during neoadjuvant therapy.

Authors:  Takayoshi Kishino; Keiichi Okano; Yasuhisa Ando; Hironobu Suto; Eisuke Asano; Minoru Oshima; Masao Fujiwara; Hisashi Usuki; Hideki Kobara; Tsutomu Masaki; Emi Ibuki; Yoshio Kushida; Reiji Haba; Yasuyuki Suzuki
Journal:  Surg Case Rep       Date:  2018-06-25

9.  Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus.

Authors:  Sujing Liu; Hui Zhu; Wanghu Li; Baijiang Zhang; Li Ma; Zhijun Guo; Yong Huang; Pingping Song; Jinming Yu; Hongbo Guo
Journal:  Onco Targets Ther       Date:  2016-02-22       Impact factor: 4.147

10.  Mediastinal node staging by positron emission tomography-computed tomography and selective endoscopic ultrasound with fine needle aspiration for patients with upper gastrointestinal cancer: Results from a regional centre.

Authors:  Chris Harrington; Lyn Smith; Jennifer Bisland; Elisabet López González; Neil Jamieson; Stuart Paterson; Adrian John Stanley
Journal:  World J Gastrointest Endosc       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.